EDWARDS INTUITY ELITE VALVE SYSTEM
Edwards Lifesciences, LLC · Decision date Aug 12, 2016
What did the FDA approve?
FDA approved the EDWARDS INTUITY Elite Valve System on August 12, 2016, under PMA number P150036. The approval record states the device is indicated for replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves. The applicant was Edwards Lifesciences, LLC, and the product code is LWR, classified as a non-allograft tissue heart valve in the cardiovascular specialty.
This record is an original PMA approval, not a supplement. No supplement type or supplement reason is listed. The decision field contains only the approval and indication statement; the record does not include clinical data, performance outcomes, or safety findings. The stated indication describes the intended replacement scope, but the source does not independently establish safety or effectiveness.
FDA approval order statement
Approval for the EDWARDS INTUITY Elite Valve System. This device is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 12, 2016
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150036
- Regulatory pathway
- Premarket approval application
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- Decision code
- APPR
- Decision date
- Aug 12, 2016
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P150036 received
Application receipt date recorded by FDA.
P150036 · FDA decision
APPR
P150036/S081 · Related supplement
EDWARDS INTUITY Elite Valve System (8300AB)
Timeline entries are records held by MedtechLedger for P150036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA approval | Jun 29, 2017 | FDA | |
| ABBOTT MEDICAL | PMA approval | Aug 5, 2005 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P150036
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records